Cargando…
The Calcium Culprit: A Case of Denosumab-induced Hypocalcemia
Denosumab is a fully human monoclonal antibody which is used to treat osteoporosis and has been shown to cause hypocalcemia in patients with underlying prostatic and bone malignancies, renal impairment, postmenopausal state, and/or vitamin D deficiency. We present a case of a male patient, with a pa...
Autores principales: | Kalayanamitra, Ricci, Yaghnam, Ibrahim, Patel, Ravi, Groff, Andrew, Jain, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663059/ https://www.ncbi.nlm.nih.gov/pubmed/31363449 http://dx.doi.org/10.7759/cureus.4768 |
Ejemplares similares
-
Severe Refractory Hypocalcemia Caused by Denosumab
por: Dadana, Sriharsha, et al.
Publicado: (2023) -
Hypocalcemia in a Patient With Metastatic Prostate Cancer From Denosumab Treatment
por: Gouli, Sugam, et al.
Publicado: (2021) -
Diagnosis and Management of Denosumab-Induced Hypocalcemia and Hypophosphatemia in the Setting of Metastatic Prostate Cancer
por: Flood, Michael G, et al.
Publicado: (2022) -
Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia
por: Tinawi, Mohammad
Publicado: (2021) -
Hypocalcemia Induced Bronchospasm
por: Kumari, Aneeta, et al.
Publicado: (2022)